Evidence map›Paper›PMID 29383405›Full record

SynthesisStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2018

Individualization of post-mastectomy radiotherapy and regional nodal irradiation based on treatment response after neoadjuvant chemotherapy for breast cancer : A systematic review.

David Krug, René Baumann, Wilfried Budach, Jürgen Dunst, Petra Feyer, Rainer Fietkau, Wulf Haase, Wolfgang Harms, Thomas Hehr, Marc D Piroth and 4 more

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Trial
  4. Therapy of early breast cancer: current status and perspectives.Archives of gynecology and obstetrics · 2025
    Review
  5. Axillary lymph node management strategies in cN + breast cancer patients after neoadjuvant chemotherapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Effect of hypofractionation on the incidental axilla dose during tangential field radiotherapy in breast cancer.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2020
    Article
  13. Long-term quality of life after preoperative radiochemotherapy in patients with localized and locally advanced breast cancer.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2020
    Article
  14. Article
  15. Post-Neoadjuvant Therapy.Breast care (Basel, Switzerland) · 2019
    Article
  16. Article
  17. Review
  18. Long-term cosmetic outcome after preoperative radio-/chemotherapy in locally advanced breast cancer patients.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2019
    Article
  19. Challenges in Radiotherapy.Breast care (Basel, Switzerland) · 2019
    Article
  20. Neoadjuvant chemotherapy for breast cancer-background for the indication of locoregional treatment.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 12 institutions in 3 countries.

David KrugDepartment of Radiation Oncology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany. david.krug@med.uni-heidelberg.de.
René BaumannUniversity Hospital Schleswig-Holstein, Kiel, Germany.
Wilfried BudachHeinrich-Heine-University, Duesseldorf, Germany.
Jürgen DunstUniversity Hospital Schleswig-Holstein, Kiel, Germany.
Petra FeyerVivantes Hospital Neukoelln, Berlin, Germany.
Rainer FietkauUniversity Hospital Erlangen, Erlangen, Germany.
Wulf HaaseFormerly St.-Vincentius-Hospital, Karlsruhe, Germany.
Wolfgang HarmsSt. Claraspital, Basel, Switzerland.
Thomas HehrDepartment of Radiation Oncology, Marienhospital Stuttgart, Stuttgart, Germany.
Marc D PirothHELIOS-Hospital Wuppertal, Witten/Herdecke University, Wuppertal, Germany.
Felix SedlmayerParacelsus Medical University Hospital, Salzburg, Austria.
Rainer SouchonFormerly University Hospital Tuebingen, Tuebingen, Germany.
Frederik WenzUniversitätsmedizin Mannheim, Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany.
Rolf SauerUniversity Hospital Erlangen, Erlangen, Germany.
Universitätsklinikum Erlangen · DEHeidelberg University · DEHeinrich Heine University Düsseldorf · DEHelios Universitätsklinikum Wuppertal · DEMarienhospital Stuttgart · DEParacelsus Medical University · ATSt. Claraspital · CHSt. Vincentius-Kliniken · DEUniversity Hospital Heidelberg · DEUniversity Hospital Schleswig-Holstein · DEUniversity of Lübeck · DEVivantes Klinikum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo review the evidence regarding post-mastectomy radiotherapy (PMRT) and regional nodal irradiation (RNI) after neoadjuvant chemotherapy (NACT) for breast cancer, with a special focus on individualization of adjuvant radiotherapy based on treatment response.

methodsA systematic literature search using the PubMed/Medline database was performed. We included prospective and retrospective reports with a minimum of 10 patients that had been published since 1

resultsOut of 763 articles identified via PubMed/Medline and hand search, 68 full text-articles were assessed for eligibility after screening of title and abstract. 13 studies were included in the systematic review, 9 for PMRT and 5 for RNI. All included studies were retrospective reports.

conclusionsThere is a considerable lack of evidence regarding the role of adjuvant radiotherapy and its individualization based on treatment response after NACT. Results of prospective randomized trials such as NSABP B‑51/RTOG 1304 and Alliance A11202 are eagerly awaited.

Indexed as

Chemotherapy, AdjuvantMastectomyNeoadjuvant TherapyPrecision MedicineBreast NeoplasmsCombined Modality TherapyFemaleHumansLymphatic IrradiationRadiotherapy, AdjuvantBreast neoplasmsLocal recurrenceNeoadjuvant therapyRadiotherapy

Identifiers

PMID29383405
OpenAlexW2793281772

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.